Skip to main content
BMC Medicine logoLink to BMC Medicine
. 2023 Jan 8;21:15. doi: 10.1186/s12916-022-02718-1

Correction: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)

Meichen Li 1,#, Jing Chen 1,#, Baishen Zhang 1,#, Juan Yu 1, Na Wang 2, Delan Li 3, Yang Shao 4,5, Dongqin Zhu 5, Chuqiao Liang 5, Yutong Ma 5, Qiuxiang Ou 5, Xue Hou 1,, Likun Chen 1,
PMCID: PMC9827667  PMID: 36617568

Correction: BMC Med 20, 398 (2022)

https://doi.org/10.1186/s12916-022-02595-8

The original article [1] contained two errors in Fig. 4:

  1. The labels of the two groups – response vs. non-response – were mistakenly switched.

  2. The HR in panel A was incorrectly stated as 0.38 instead of 0.308.

The figure has been updated in the original article to reflect these amendments.

Footnotes

Meichen Li, Jing Chen and Baishen Zhang contributed equally to this work.

Contributor Information

Xue Hou, Email: houxue@sysucc.org.cn.

Likun Chen, Email: sysuchenlk@163.com.

Reference

  • 1.Li M, et al. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028) BMC Med. 2022;20:398. doi: 10.1186/s12916-022-02595-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Medicine are provided here courtesy of BMC

RESOURCES